Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
Deborah Hibbett/LinkedIn
Dec 18, 2025, 14:15

Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List

Deborah Hibbett, Senior Vice President, Head of Global Corporate Affairs and Sustainability, Plasma-Derived Therapies at Takeda, shared on LinkedIn:

”The updated European Medicines Agency’s Union List of Critical Medicines now includes a plasma-derived therapy for hemophilia patients with inhibitors.

This addition underscores that reliable, uninterrupted access to critical medicines – including this product and the other listed plasma-derived therapies – is essential for patients, families and healthcare systems.

Takeda celebrates this update as we are also committed to the bleeding disorders community and to creating value through sustainable, equitable access – including our renewed collaboration with the WFH Humanitarian Aid Program and the work highlighted in Takeda’s 2025 Access to Medicines Update.

Thank you to the healthcare community, patient advocates and partners who continue to advance security of supply and equity in care every day.”

Stay updated with Hemostasis Today.

bleeding disorders Deborah Hibbett European Medicines Agency Health Hematology Hemophilia Hemostasis Hemostasis Today Medicine Takeda’s WFH
NewsFeed